PEERS Program for Opioid Use Disorder
(PEERS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new support program for individuals starting medication treatment for opioid use disorder. The PEERS Program pairs participants with a Certified Recovery Specialist for regular support sessions over six months. The goal is to determine if this support helps individuals adhere to their treatment. Those who recently began medication for opioid use disorder at a Geisinger clinic and are open to additional support might be suitable candidates. Participant feedback will help refine the program for future use. As an unphased trial, this study provides a unique opportunity to contribute to the development of innovative support strategies for opioid use disorder.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study focuses on supporting patients already on medication for opioid use disorder, it seems likely that you can continue your current treatment.
What prior data suggests that the PEERS Program is safe for participants?
Research has shown that peer support programs are generally safe and well-received. In these programs, trained peers assist individuals with opioid use disorder (OUD) in staying engaged with their treatment. Studies have found that this type of support can significantly improve treatment retention and may reduce opioid-related deaths by up to 50%. Although specific data on negative effects from peer support is lacking, its focus on emotional and motivational support suggests it is low risk.
The PEERS program does not use medication or involve any medical procedures. Instead, it employs Certified Recovery Specialists (CRS) to support participants through regular meetings. Because this method relies on conversation and support, it is considered safe for participants.12345Why are researchers excited about this trial?
The PEERS Program for Opioid Use Disorder stands out because it offers personalized, peer-driven support through certified recovery specialists. Unlike traditional treatments that may rely heavily on medication or structured therapy sessions, this program emphasizes flexibility and patient-centered care. Participants work one-on-one with a recovery specialist to tailor their sessions, choosing when, where, and how often they meet, whether that's in a clinic or at a local coffee shop. Researchers are excited about this approach because it empowers individuals to take charge of their recovery journey, potentially leading to more sustainable outcomes.
What evidence suggests that the PEERS Program is effective for opioid use disorder?
Research has shown that peer recovery support programs can greatly help people with opioid use disorder (OUD). One study found that these programs improved participation in treatment and increased the chances of staying in recovery. Another study showed that peer support in emergency rooms helped lower the risk of future overdoses. In this trial, participants will receive services from a certified recovery specialist through the Peer Recovery Support program. This approach connects patients with individuals who have faced similar challenges, providing understanding and encouragement. Such social support is crucial for overcoming substance use disorders.14678
Who Is on the Research Team?
Melissa Poulsen, PhD
Principal Investigator
Geisinger Clinic
Are You a Good Fit for This Trial?
This trial is for adults over 18 who have recently started medication treatment for opioid use disorder at specific outpatient clinics. Participants must be willing to engage in the PEERS program and able to give consent.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the PEERS program, entailing regular sessions with a Certified Recovery Specialist for 6 months
Assessment
Participants complete assessments at baseline and 12 weeks, and provide qualitative feedback through an interview conducted between 8-12 weeks
Follow-up
Participants are monitored for engagement and acceptability of the program, and CRS fidelity to the program
What Are the Treatments Tested in This Trial?
Interventions
- PEERS Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Geisinger Clinic
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
UConn Health
Collaborator